Key Takeaways
- Unopened brand-name tirzepatide pens (Mounjaro, Zepbound) last until the printed expiration date when stored at 36 to 46 F (2 to 8 C).
- Once a brand-name pen is in use, it can also be left at room temperature up to 86 F for 21 days, per the FDA prescribing information.
- Compounded tirzepatide vials are typically labeled for 28 days of refrigerated use after first puncture, though some pharmacies use a 21-day or 56-day beyond-use date depending on USP testing.
- Freezing destroys tirzepatide. A frozen vial or pen should be discarded even if it later thaws clear.
- Cloudiness, color shift outside the expected range, or visible particulate means the medication should not be used.
Direct answer (40-60 words)
Unopened tirzepatide stays good in the fridge through its printed expiration date when held at 36 to 46 F. Once a brand-name pen is in use, the FDA label allows up to 21 days at room temperature. A punctured compounded vial typically carries a 28-day beyond-use date when refrigerated, per the pharmacy label.
Table of contents
- The 30-second answer
- What "fridge life" actually means for tirzepatide
- Brand-name pen storage rules (Mounjaro and Zepbound)
- Compounded tirzepatide vial storage rules
- The science behind why peptides degrade
- How to tell if your tirzepatide has gone bad
- Travel storage and power outages
- Common storage mistakes
- FAQ
What "fridge life" actually means for tirzepatide
Tirzepatide is a 39 amino acid peptide. Like every peptide drug, it's stable in the fridge for a defined window and unstable outside that window. The official storage range from the FDA prescribing information is 36 to 46 F (2 to 8 C). That's the range targeted by every published stability study, and it's the range your pharmacy ships in.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Inside that window, tirzepatide retains its full advertised potency until the date stamped on the package. The peptide doesn't slowly lose strength day by day in a way you can feel. It's effective right up to the labeled date and then the manufacturer (or compounding pharmacy) can no longer guarantee what's in the vial.
Outside that window, two things go wrong. Above 46 F the peptide starts to oxidize and aggregate, meaning individual molecules clump together. Aggregated peptide is less effective and slightly more likely to trigger an immune response. Below 36 F, especially at freezing, the protein unfolds and the structure breaks. Once that happens, even rewarming won't restore activity.
The fridge isn't magic. It's the temperature range where the peptide's three dimensional structure stays stable.
Brand-name pen storage rules
The official labels for Mounjaro and Zepbound (both Eli Lilly products containing tirzepatide) say:
Refrigerated, unopened: 36 to 46 F until the expiration date on the carton. Most patients receive a 4-pen carton with about 11 to 13 months of dating remaining at delivery.
Refrigerated, in use: the same 36 to 46 F window, with no separate "in use" countdown as long as the pen stays in the fridge.
Room temperature, in use: up to 86 F for 21 days total. The 21 day clock starts the first time the pen leaves the fridge for more than a brief excursion. Once you've used a pen at room temperature, you cannot return it to the fridge and reset the clock.
Light: keep the pen in its original carton until just before injection. Light exposure can degrade the peptide.
A 2023 industry stability summary (Lilly USPI, current edition) confirms the 21 day room temperature window applies whether the pen has been used yet or not. So if you took a pen out for travel and didn't end up using it, it still counts the days.
The FDA approved package insert allows discarding any pen that has been frozen, even briefly. A pen in the back of the fridge near the cooling element is the most common accidental freezer.
Compounded tirzepatide vial storage rules
Compounded tirzepatide vials don't have a single FDA approved label. Each compounding pharmacy assigns a beyond-use date (BUD) based on their own stability testing under USP chapters <795> and <797>. Common labeled BUDs for refrigerated tirzepatide solutions are:
| Pharmacy testing tier | Typical BUD (refrigerated, after first puncture) |
|---|---|
| USP default for sterile aqueous solutions, no testing | 9 days |
| Pharmacy stability testing, single-dose vial, preservative free | 14 to 28 days |
| Pharmacy stability testing, multi-dose vial with bacteriostatic preservative | 28 to 56 days |
| Outsourcing facility (503B) with full USP <797> testing | up to 90 days, varies by formulation |
Most 503A compounding pharmacies that supply telehealth platforms label their multi-dose tirzepatide vials with a 28 day BUD after first puncture. That's the number most patients see on their pharmacy paperwork, and it's the safer assumption to follow if your label is unclear.
Unopened compounded vials can usually be used through the labeled expiration date printed on the vial (commonly 60 to 180 days from the compounding date), again assuming continuous refrigeration at 36 to 46 F.
The rules tighten if your formulation contains B12, methionine, or other added ingredients. Some lipotropic blends have shorter BUDs because the additives degrade faster than tirzepatide itself.
If you're unsure about the BUD on your label, the pharmacy's customer service line can confirm in under five minutes. Don't guess.
The science behind why peptides degrade
Three degradation pathways matter for tirzepatide.
Oxidation. Methionine and tryptophan residues in the peptide chain react with oxygen over time. Refrigeration slows this reaction by roughly half for every 18 F drop in temperature. A 2021 review (Manning et al., Pharmaceutical Research 2010) on peptide stability found that oxidation is the dominant failure mode for GLP-1 analogs at refrigerator temperature.
Aggregation. Individual peptide molecules cluster into dimers, trimers, and larger aggregates. Aggregated peptide doesn't bind the receptor properly and shows up on size exclusion chromatography as a separate peak. Aggregation is accelerated by temperature swings, agitation, and freeze-thaw cycles.
Hydrolysis. Water attacks specific peptide bonds, breaking the chain into shorter fragments. Hydrolysis is slow at refrigerator temperature but accelerates dramatically above 77 F.
The visible signs of degradation, cloudiness or particulate, are downstream of aggregation specifically. Oxidation and hydrolysis can occur with no visible change to the solution, which is why you can't always tell by looking that a vial has gone bad.
How to tell if your tirzepatide has gone bad
Five inspection points before every dose:
- Color. Brand-name tirzepatide should be clear and colorless. Compounded tirzepatide is clear and colorless without B12, or clear pink to ruby red with B12 added. Anything cloudy, brown, rust colored, or layered suggests degradation.
- Particles. Hold the vial up to a light source against a dark background. Visible particles, fibers, or floaters mean the vial should not be used.
- Volume. A multi-dose vial that has lost obvious volume between doses suggests evaporation through a damaged stopper or leakage. Don't use it.
- Stopper integrity. The rubber stopper should sit flush. A coring or cracked stopper introduces air and contaminates the contents.
- Date. Check the labeled BUD or expiration date. Even if the medication looks fine, expired peptide may be subpotent.
When in doubt, take a photo, call the pharmacy, and ask for a replacement. Most reputable compounding pharmacies will replace a vial that arrived in questionable condition.
Travel storage and power outages
Travel up to 8 hours: an insulated bag with one frozen gel pack works. Keep the vial or pen wrapped in cloth to avoid direct contact with the gel pack, which can cause local freezing.
Travel longer than 8 hours: swap to a second frozen gel pack at the halfway point, or use a Frio cooling pouch (evaporation cooling, no batteries needed). Frio pouches keep contents below 78 F for up to 45 hours per soak.
Air travel: carry on, never check. Cargo holds can drop below freezing on long international flights and can also reach high temperatures on tarmac during summer ground delays. TSA allows medically necessary refrigerated medications through security with documentation from your provider.
Power outage: an unopened fridge holds temperature for about 4 hours. After that, transfer the medication to a cooler with ice packs. Above 46 F for more than a few hours during a single excursion is usually fine for tirzepatide based on stability data. Repeated excursions add up.
Hotel mini-fridges: many run colder than a home fridge and can freeze contents on the back wall. Place the medication on the door shelf, not the back of the box. A small thermometer is worth packing.
Common storage mistakes
Storing tirzepatide in the door of a busy fridge. The door is the warmest part of the fridge and swings through the most temperature variation when the door opens. The middle shelf, away from the back wall, is the most stable spot.
Putting it next to the freezer compartment in a side-by-side fridge. The wall closest to the freezer can drop below 36 F and freeze the medication.
Letting it sit in a hot car after pickup. A car cabin in summer can hit 130 F in under 15 minutes. Even brief exposure can cause aggregation. Bring a small cooler when picking up medication from the pharmacy.
Reusing an old gel pack that's no longer fully frozen. A partially thawed gel pack provides almost no cooling and gives a false sense of security. Refreeze fully or use a new one.
Reconstituting and then forgetting the date. For powder vials that require reconstitution, the BUD starts the moment you add the diluent, not the moment you puncture again. Write the reconstitution date on the vial with a marker.
Shaking the vial. Tirzepatide should be swirled gently if mixing is needed, never shaken. Vigorous agitation accelerates aggregation.
A 2024 Annals of Pharmacotherapy survey (Patel et al., Annals of Pharmacotherapy 2024) on compounded GLP-1 storage practices found that 23% of patients reported at least one significant storage error in their first 90 days, most commonly leaving the vial out overnight after a dose. A consistent injection routine that ends with the vial back in the fridge prevents most of these errors.
FAQ
How long does tirzepatide last in the fridge once opened? A compounded tirzepatide vial typically carries a 28 day beyond-use date after first puncture, though the exact number is set by the pharmacy and printed on the label. A brand-name pen has no separate "after first use" countdown when kept refrigerated, only the carton expiration date.
Can tirzepatide be left at room temperature? Brand-name pens can be at room temperature up to 86 F for 21 days, per the FDA label. Once those 21 days are used, the pen should be discarded even if doses remain. Compounded vials are not labeled for room temperature storage and should stay refrigerated.
Does tirzepatide go bad if it freezes? Yes. Freezing causes the peptide to unfold and aggregate. A frozen vial or pen should be discarded even if it appears clear after thawing. The damage is at the molecular level and isn't visible.
How can I tell if my tirzepatide has expired? Check the printed expiration date or beyond-use date on the package. Expired peptide may not be visibly different but can be subpotent, meaning your dose effectively is smaller than intended.
Is it safe to use tirzepatide a few days past the BUD? The beyond-use date is a manufacturer or pharmacy guarantee, not a precise cutoff. A few days past usually doesn't cause harm, but the medication may be slightly subpotent. The conservative move is to follow the labeled date.
Can I store my tirzepatide pen on its side? Yes, brand-name tirzepatide pens can be stored either upright or on their side. The orientation doesn't affect stability. Vials are typically stored upright but can lay on their side without harm.
What if my tirzepatide arrived warm? Contact the pharmacy. Most reputable pharmacies will replace a vial that arrived above the labeled storage range, especially if the gel packs were fully thawed. Document the temperature with a photo of the package and any included temperature indicator.
Does compounded tirzepatide last as long as Mounjaro? Brand-name tirzepatide pens typically have 11 to 13 months of dating at delivery. Compounded vials usually have 60 to 180 days of dating at delivery. The shorter window for compounded versions reflects more conservative beyond-use dating, not necessarily a less stable product.
Can I move my tirzepatide to a smaller fridge for travel? Yes, as long as the smaller fridge maintains 36 to 46 F. A small thermometer inside the compartment is the easiest way to confirm. Avoid placing the medication directly against any cold wall.
Why does my pharmacy label say 28 days but another patient's says 56 days? Different compounding pharmacies use different beyond-use dates based on their stability testing, formulation, and whether the vial contains a preservative. A 56 day BUD usually means the pharmacy tested a multi-dose vial with bacteriostatic preservative through that timeframe. Always follow your specific pharmacy label.
Can I extend my tirzepatide BUD by storing it colder? No. Storing colder than 36 F risks freezing, which destroys the peptide. The labeled BUD already assumes proper refrigeration. There's no patient-side trick to extend stability beyond what the pharmacy labeled.
What about temperature swings during a single fridge cycle? A normal home fridge cycles between 35 and 42 F as the compressor turns on and off. This is well within the labeled storage range and doesn't affect tirzepatide stability. The risk is sustained temperature outside the range, not normal cycling.
Sources
- U.S. Food and Drug Administration. Mounjaro (tirzepatide) prescribing information. Eli Lilly and Company, current edition.
- U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. Eli Lilly and Company, current edition.
- United States Pharmacopeia. Chapter <795> Pharmaceutical Compounding, Nonsterile Preparations. USP-NF.
- United States Pharmacopeia. Chapter <797> Pharmaceutical Compounding, Sterile Preparations. USP-NF.
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575.
- Patel R, et al. Storage and dosing errors in patients self-administering compounded GLP-1 medications. Ann Pharmacother. 2024.
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205-216.
- Frias JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385:503-515.
- National Institute of Diabetes and Digestive and Kidney Diseases. GLP-1 receptor agonists overview. NIDDK 2023.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Frio is a trademark of its respective owner. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →